Researchers from the University of Copenhagen have discovered a new weight loss drug target that works without causing nausea ...
Stopping semaglutide, marketed as Wegovy and Ozempic, which helps people lose weight , can have severe health impacts, a new ...
A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found that the GLP-1 agonists semaglutide and liraglutide, which are used for treating diabetes and obesity, ...
In a study of around 228,000 people in Sweden who had alcohol use disorder, researchers found that people who were taking a ...
Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible ...
Semaglutide and liraglutide are associated with reduced AUD and SUD-related hospitalization risks, unlike other GLP-1 ...
Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...
Ro details dietary choices that may help Wegovy's capacity to regulate appetite and foster a healthier weight as well as ...
Whether these departments get the money will be decided later, but the Scene listened in on requests from the Department of ...
With the rising popularity of telehealth providers offering GLP-1 medications like Ozempic, the terminology can get confusing ...
A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the ...
While the West Virginia Public Employees Insurance Agency Finance Board is on the road for public meetings getting feedback from state government workers, local government workers, and retirees ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback